PV
| |
PROFUND VP BIOTECHNOLOGYMutual Fund | |
| PROFUNDS | |
| Last update 2026-05-20 | 147 Stocks (11 new) |
| Value $41.00 Mil | Turnover 12 % |
PROFUND VP BIOTECHNOLOGY Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 18,547 | 746.1 | +24.86% | 1.840 | +0.37% | 0.010 | +89.08% | +63.34% | 5,252.7 | Biotechnology | |
ALKS | Alkermes PLC | 16,692 | 590.2 | -5.21% | 1.450 | -0.06% | 0.010 | +82.69% | +95.35% | 9,110.5 | Drug Manufacturers | |
MDGL | Madrigal Pharmaceuticals Inc | 1,074 | 562.2 | +17.76% | 1.380 | +0.21% | 0.000 | +1.40% | -9.67% | 12,127.4 | Biotechnology | |
TGTX | TG Therapeutics Inc | 16,526 | 549.0 | +0.34% | 1.350 | 0% | 0.010 | +71.73% | +84.23% | 8,407.4 | Biotechnology | |
INSM | Insmed Inc | 3,325 | 543.7 | +25.24% | 1.340 | +0.27% | 0.000 | -27.54% | -38.55% | 23,182.8 | Biotechnology | |
SRRK | Scholar Rock Holding Corp | 10,735 | 527.7 | -4.04% | 1.300 | -0.05% | 0.010 | +21.44% | +21.88% | 6,433.6 | Biotechnology | |
APGE | Apogee Therapeutics Inc | 6,207 | 522.4 | +47.36% | 1.290 | +0.41% | 0.010 | +69.16% | +75.75% | 9,973.5 | Biotechnology | |
PTGX | Protagonist Therapeutics Inc | 4,805 | 506.4 | -12.87% | 1.250 | -0.15% | 0.010 | +17.64% | +37.61% | 7,729.6 | Biotechnology | |
SMMT | Summit Therapeutics Inc | 26,625 | 504.8 | +6.78% | 1.240 | +0.08% | 0.000 | -18.66% | -19.73% | 10,897.3 | Biotechnology | |
UTHR | United Therapeutics Corp | 851 | 504.6 | -18.09% | 1.240 | -0.22% | 0.000 | +2.06% | +11.54% | 23,069.8 | Drug Manufacturers |
PROFUND VP BIOTECHNOLOGY's Historical Top Holdings Breakdowns
PROFUND VP BIOTECHNOLOGY's Top Stock Picks
View Full List
| Ticker |
|---|
| RNAM Unlock Delisted |
| CDTX Unlock Delisted |
| EXAS Unlock Delisted |
MRNA |
| DVAX Unlock Delisted |
ERAS |
ROIV |
CAPR |
APGE |
PCVX |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNAM Unlock Delisted | Avidity Biosciences Inc | 2026-03-31 | Sold Out Sold Out | -1.25% | 70.63 ($71.2) 71.47 | $71.34 | 0.20% | Sold Out | 0 | -7,064 | |
| CDTX Unlock Delisted | Cidara Therapeutics Inc | 2026-03-31 | Sold Out Sold Out | -1.24% | 221.03 ($221.3) 221.38 | $221.38 | 0.04% | Sold Out | 0 | -2,295 | |
| EXAS Unlock Delisted | Exact Sciences Corp | 2026-03-31 | Sold Out Sold Out | -1.24% | 101.61 ($102.96) 104.91 | $104.91 | 1.89% | Sold Out | 0 | -4,978 | |
MRNA | Moderna Inc | 2026-03-31 | Reduce Reduce | -0.65% | 30.86 ($46.65) 57.8 | $66.57 | 42.70% | Reduce -52.28% | 8,282 | -9,074 | |
| DVAX Unlock Delisted | Dynavax Technologies Corp | 2026-03-31 | Sold Out Sold Out | -0.60% | 15.38 ($15.52) 15.72 | $15.50 | -0.13% | Sold Out | 0 | -15,934 | |
ERAS | Erasca Inc | 2026-03-31 | Add Add | +0.58% | 3.49 ($11.82) 16.18 | $15.01 | 26.99% | Add 128.12% | 25,894 | 14,543 | |
ROIV | Roivant Sciences Ltd | 2026-03-31 | Reduce Reduce | -0.49% | 21.14 ($25.69) 29.72 | $34.18 | 33.05% | Reduce -37.07% | 15,671 | -9,230 | |
CAPR | Capricor Therapeutics Inc | 2026-03-31 | New Buy New Buy | +0.48% | 21.57 ($26.64) 33.57 | $26.28 | -1.35% | New holding | 6,408 | 6,408 | |
APGE | Apogee Therapeutics Inc | 2026-03-31 | Add Add | +0.41% | 62.13 ($72.62) 84.17 | $132.66 | 82.67% | Add 47.36% | 6,207 | 1,995 | |
PCVX | Vaxcyte Inc | 2026-03-31 | Reduce Reduce | -0.40% | 44.85 ($54.29) 63.04 | $55.77 | 2.73% | Reduce -30.48% | 8,057 | -3,532 |
PROFUND VP BIOTECHNOLOGY Total Holding History ($B)
PROFUND VP BIOTECHNOLOGY's Asset Allocation
PROFUND VP BIOTECHNOLOGY Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
PROFUND VP BIOTECHNOLOGY's Hypothetical Growth since 2026-03-31
PROFUND VP BIOTECHNOLOGY's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
PROFUND VP BIOTECHNOLOGY's Holdings Heat Map
Size field: